Allarity Therapeutics, Inc. (ALLR): Shareholders' Equity
$9.83M
As of 2025-12-31
$3.54M
As of 2026-06-30
-16.7%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.83M | -16.8% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $11.81M | n/m | 2026-03-30, Balance as of period end |
| 2023-12-31 | -$2.75M | n/m | 2025-03-31, Balance as of period end |
| 2022-12-31 | -$113.0K | n/m | 2024-03-08, Balance as of period end |
| 2021-12-31 | $18.15M | -25.7% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $24.44M | n/a | 2022-05-17, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $9.83M | -16.8% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $3.76M | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$6.30M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $11.11M | +806.2% |
| America Great Health (AAGH) | 2025-06-30 | -$5.66M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.59M | +2.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $41.59M | -20.8% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $70.12M | -11.3% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$6.28M | n/m |
Compare ALLR, HIND, PVCT, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗